Exabis Library
Welcome to the e-CCO Library!
P619 Efficacy of zinc acetate hydrate administration for zinc deficiency in patients with inflammatory bowel disease: a multi-centre retrospective study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P619: Incidence of collagenous colitis in NHS Lothian: a population-based study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P619: Inflammatory bowel disease meets fertility: a physicians and patients survey
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P619: Maintenance of efficacy following tofacitinib dose reduction in patients with ulcerative colitis in stable remission
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P619: Patterns of Anti-TNF Prescribing & Therapy Outcome in a Large Multicentre Cohort of Inflammatory Bowel Disease Patients
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P619: Systematic review: Psychosocial factors associated with pain in inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P619: Tofacitinib for the treatment of resistant ulcerative colitis: the University of Chicago experience
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P620 Maintenance of clinical remission with SB5 biosimilar after switch from adalimumab originator: Real-life experience of a tertiary referral centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P620: Can ustekinumab trough and antidrug antibody levels post induction predict treatment failure?
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P620: Differences in illness perceptions of Inflammatory Bowel Disease (IBD) between Healthcare Practitioners (HCPs) and patients in a UK tertiary IBD centre.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P620: Golimumab in ulcerative colitis: A multi-centre real-world experience
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P620: Network meta-analysis of efficacy and safety of different intravenous iron compounds for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P620: Pivoting in a pandemic: The impact of COVID-19 on the provision of care for patients with Inflammatory Bowel Disease – A retrospective study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P620: Stapled end-to-side vs. side-to-side anastomosis after ileocecectomy for Crohn’s disease: a propensity score-matched analysis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P621 Physician preferences for biologics (originator vs. biosimilar) for the treatment of ulcerative colitis in France, Germany and the UK
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P621: Combination treatment of biologics with immunomodulator increases risk of infection after discharge in biologics naive steroid refractory acute severe ulcerative colitis patient: A KASID multicenter study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P621: Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P621: Faecal calprotectin after the induction of anti-TNF therapy predicts mucosal healing in patients with ulcerative colitis: A prospective single-centre study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P621: Lactose intolerance assessed by analysis of genetic polymorphism, breath test and symptoms in patients with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P621: Real-world effectiveness and safety of vedolizumab and anti-TNF in biologic-naive Crohn’s disease patients: results from the EVOLVE study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM